Gero is a pioneering biotechnology company dedicated to understanding the fundamental biology of aging and developing novel therapeutics to combat age-related diseases and extend healthy human lifespans. Leveraging advanced AI and machine learning, Gero analyzes large-scale biological data, including human health records and genetic information, to identify new drug targets and develop interventions aimed at slowing or reversing the aging process. Their research focuses on areas like resilience to stress and disease, with the ultimate goal of creating therapies that enhance healthspan and treat complex conditions.
Serves as the central hub for Gero's research and development leadership, strategic planning, global operations management, and business development in the field of longevity and AI-driven drug discovery.
Located in International Plaza, a well-known high-rise commercial and residential building in Singapore's Central Business District. The office is expected to house advanced computational infrastructure necessary for its AI-driven research and data analysis.
Gero likely fosters a highly innovative, collaborative, and research-intensive environment, bringing together experts in AI, computational biology, physics, and drug development. The culture probably emphasizes cutting-edge science, data-driven decision-making, and a strong mission-driven focus on tackling aging and improving human healthspan.
The Singapore HQ is significant due to its access to a strong talent pool, supportive government initiatives for biotech and AI, robust intellectual property protection, and its position as a gateway to the broader Asian market and global scientific collaborations.
Gero operates with a global mindset, anchored by its headquarters in Singapore and a significant presence in the key biotechnology hub of Cambridge, Massachusetts, USA. This dual presence allows the company to engage with leading scientific communities, recruit top talent internationally, foster global research collaborations, and pursue business development opportunities across Asia, North America, and Europe. Gero's AI-driven platform inherently supports distributed data analysis and collaboration, enabling its team to work on a global scale to advance the science of longevity.
10 Anson Road, #27-18, International Plaza
Singapore
Singapore
Singapore
Address: Specific street address not publicly listed, likely a research or business development office within the Cambridge/Boston biotech hub.
To tap into the world-class talent pool, leading academic research institutions, and the vibrant venture capital network concentrated in one of the world's foremost biotechnology clusters, advancing Gero's drug discovery programs targeting aging.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Gero' leadership includes:
Gero has been backed by several prominent investors over the years, including:
In the last 12 months (May 2023 - May 2024), Gero significantly strengthened its clinical development capabilities with the strategic appointment of Dr. Andrey Lovat as Head of Clinical Development. No major executive departures have been publicly announced during this period, indicating stability in its core leadership team.
Discover the tools Gero uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Gero primarily utilizes the email format consisting of the employee's first name followed by a period, then their last name, all preceding '@gero.ai'. This is a common and professional email structure in the technology and biotechnology sectors.
first.last@gero.ai
Format
peter.fedichev@gero.ai
Example
85%
Success rate
BioSpace • April 18, 2024
Gero announced the discovery of novel therapeutic targets for Amyotrophic Lateral Sclerosis (ALS) using its AI platform. These targets were subsequently validated in vivo in animal models, highlighting a potential new avenue for developing treatments for the debilitating neurodegenerative disease....more
Business Wire • March 27, 2024
Gero, in collaboration with Pfizer, published research in a peer-reviewed journal demonstrating that AI can identify interventions capable of reversing the biological burden of age-related diseases. This study suggests a new paradigm for therapeutic development in chronic illnesses by focusing on resilience and aging clocks....more
Business Wire • July 20, 2023
Gero announced the appointment of Andrey Lovat, MD, PhD, as its Head of Clinical Development. Dr. Lovat brings significant experience in clinical research and drug development to Gero and will lead the company's efforts to translate its AI-driven discoveries into clinical therapies....more
Longevity.Technology • July 10, 2023
Gero published research detailing an AI model that quantifies the link between the aging process and a decline in physiological resilience. This model offers new insights into the mechanisms of aging and could lead to the development of novel biomarkers and interventions for age-related conditions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Gero, are just a search away.